These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8361029)

  • 21. Effects of rheumatoid factor, antinuclear antibodies and plasma reagin on the serologic assay for Lyme disease.
    Lovece S; Stern R; Kagen LJ
    J Rheumatol; 1991 Dec; 18(12):1813-8. PubMed ID: 1795317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ANA+ (anti-nuclear antibody) is correlated with RF+ (rheumatoid factor) in rheumatoid arthritis.
    Matsos MP; Pope JE; Spencer-Green G
    Inflammopharmacology; 2004; 12(3):229-31. PubMed ID: 15527547
    [No Abstract]   [Full Text] [Related]  

  • 23. Autoantibodies in early seropositive rheumatoid arthritis, before and during disease modifying antirheumatic drug treatment.
    Paulus HE; Wiesner J; Bulpitt KJ; Patnaik M; Law J; Park GS; Wong WK
    J Rheumatol; 2002 Dec; 29(12):2513-20. PubMed ID: 12465144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
    Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
    J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Nationwide survey for autoantibodies and proposal of a new method for standardization of rheumatoid factors].
    Kumagai S; Hayashi N; Ohta T; Akahoshi T; Imafuku Y; Koshiba M
    Rinsho Byori; 2009 Jan; 57(1):31-41. PubMed ID: 19227188
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Associations between serum anti-CCP antibody, rheumatoid factor levels and HLA-DR4 expression in Hungarian patients with rheumatoid arthritis.
    Kapitány A; Szabó Z; Lakos G; Aleksza M; Végvári A; Soós L; Karányi Z; Sipka S; Szegedi G; Szekanecz Z
    Isr Med Assoc J; 2008 Jan; 10(1):32-6. PubMed ID: 18300568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Usefulness of autoantibodies in the study of autoimmune liver diseases and prevalence of autoimmune extrahepatic manifestations].
    Montes Santiago J; Gambón Deza F; García García MJ; González Vázquez L; Hermo Brión JA; Pérez Alvarez R
    An Med Interna; 2000 Jul; 17(7):343-6. PubMed ID: 10981329
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of circulating antibodies against double-stranded and single-stranded DNA with thyroid autoantibodies in Graves' disease and Hashimoto's thyroiditis patients.
    Pedro AB; Romaldini JH; Americo C; Takei K
    Exp Clin Endocrinol Diabetes; 2006 Jan; 114(1):35-8. PubMed ID: 16450315
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
    Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
    J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of antinuclear antibodies and rheumatoid factor in healthy Turkish children.
    Kasapçopur O; Ozbakir F; Arisoy N; Ingöl H; Yazici H; Ozdoğan H
    Turk J Pediatr; 1999; 41(1):67-71. PubMed ID: 10770678
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
    Vos PA; Bast EJ; Derksen RH
    Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
    Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on production of anticollagen antibodies in silicosis.
    Nagaoka T; Tabata M; Kobayashi K; Okada A
    Environ Res; 1993 Jan; 60(1):12-29. PubMed ID: 8432262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
    Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
    Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic response to blood group substance in scleroderma.
    Stringa SG; Avalos JC; Andrada JA; Casala A; Bianchi C
    Arch Dermatol; 1971 Apr; 103(4):394-9. PubMed ID: 4103900
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autoimmune phenomena in the elderly].
    Pérez L; Rodríguez C; Sepúlveda JA; Silva MC
    Rev Med Chil; 1991 Mar; 119(3):287-92. PubMed ID: 1842122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Use of autoantibodies in clinical practice].
    Petitpierre S; Aubert V; Leimgruber A; Spertini F; Bart PA
    Rev Med Suisse; 2009 Apr; 5(199):823-31. PubMed ID: 19441748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antinuclear antibodies: clinical applications.
    Wanchu A
    J Postgrad Med; 2000; 46(2):144-8. PubMed ID: 11013488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of autoantibody detection.
    Goudie RB
    J R Coll Physicians Lond; 1970 Jan; 4(2):146-53. PubMed ID: 4940181
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.